Phenethyl isothiocyanate: A comprehensive review of anti-cancer mechanisms

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1846, Issue 2, 2014, Pages 405-424

  Gupta, Parul ^a   Wright, Stephen E ^a   Kim, Sung Hoon ^b   Srivastava, Sanjay K ^a,b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Kyung Hee University   (South Korea)

Author keywords

Chemoprevention; Cruciferous vegetables; Isothiocyanates; PEITC; Reactive oxygen species

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLUTATHIONE; GLUTATHIONE TRANSFERASE; MICRORNA; PHENETHYL ISOTHIOCYANATE; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TUMOR MARKER; ANTINEOPLASTIC AGENT; ISOTHIOCYANIC ACID DERIVATIVE;

ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; AUTOPHAGY; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER STEM CELL; CELL CYCLE REGULATION; CELL DIVISION; CELL ENERGY; CELL METABOLISM; CHEMOPROPHYLAXIS; CLINICAL TRIAL (TOPIC); CRUCIFEROUS VEGETABLE; DIETARY INTAKE; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; DRUG SELECTIVITY; EPIGENETICS; EVIDENCE BASED MEDICINE; HUMAN; IMMUNOMODULATION; METASTASIS INHIBITION; NONHUMAN; PROTEIN MODIFICATION; PROTEIN POLYMORPHISM; REVIEW; SMOKING; TIME TO MAXIMUM PLASMA CONCENTRATION; VEGETABLE; ANIMAL; BRASSICACEAE; DRUG EFFECTS; METABOLISM;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; BRASSICACEAE; HUMANS; ISOTHIOCYANATES; REACTIVE OXYGEN SPECIES; VEGETABLES;

EID: 84907692711     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2014.08.003     Document Type: Review

References (216)

1. Newman D.J., Cragg G.M. Natural products as sources of new drugs over the 30years from 1981 to 2010. J. Nat. Prod. 2012, 75:311-335.
2. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
3. Higdon J.V., Delage B., Williams D.E., Dashwood R.H. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol. Res. 2007, 55:224-236.
4. Boggs D.A., Palmer J.R., Wise L.A., Spiegelman D., Stampfer M.J., Adams-Campbell L.L., Rosenberg L. Fruit and vegetable intake in relation to risk of breast cancer in the Black Women's Health Study. Am. J. Epidemiol. 2010, 172:1268-1279.
5. Tang L., Zirpoli G.R., Guru K., Moysich K.B., Zhang Y., Ambrosone C.B., McCann S.E. Intake of cruciferous vegetables modifies bladder cancer survival. Cancer Epidemiol. Biomark. Prev. 2010, 19:1806-1811.
6. Palmer S. Diet, nutrition, and cancer. Progr. Food Nutr. Sci. 1985, 9:283-341.
7. Verhoeven D.T., Goldbohm R.A., van Poppel G., Verhagen H., van den Brandt P.A. Epidemiological studies on brassica vegetables and cancer risk. Cancer Epidemiol. Biomark. Prev. 1996, 5:733-748.
8. Moy K.A., Yuan J.M., Chung F.L., Wang X.L., Van Den Berg D., Wang R., Gao Y.T., Yu M.C. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms and gastric cancer risk: a prospective study of men in Shanghai, China. Int. J. Cancer 2009, 125:2652-2659.
9. Carpenter C.L., Yu M.C., London S.J. Dietary isothiocyanates, glutathione S-transferase M1 (GSTM1), and lung cancer risk in African Americans and Caucasians from Los Angeles County, California. Nutr. Cancer 2009, 61:492-499.
10. Truong T., Baron-Dubourdieu D., Rougier Y., Guenel P. Role of dietary iodine and cruciferous vegetables in thyroid cancer: a countrywide case-control study in New Caledonia. Cancer Causes Control 2010, 21:1183-1192.
11. Lam T.K., Ruczinski I., Helzlsouer K.J., Shugart Y.Y., Caulfield L.E., Alberg A.J. Cruciferous vegetable intake and lung cancer risk: a nested case-control study matched on cigarette smoking. Cancer Epidemiol. Biomark. Prev. 2010, 19:2534-2540.
12. Wu Q.J., Yang Y., Vogtmann E., Wang J., Han L.H., Li H.L., Xiang Y.B. Cruciferous vegetables intake and the risk of colorectal cancer: a meta-analysis of observational studies. Ann. Oncol. 2013, 24:1079-1087.
13. Wu Q.J., Xie L., Zheng W., Vogtmann E., Li H.L., Yang G., Ji B.T., Gao Y.T., Shu X.O., Xiang Y.B. Cruciferous vegetables consumption and the risk of female lung cancer: a prospective study and a meta-analysis. Ann. Oncol. 2013, 24:1918-1924.
14. Lee S.A., Fowke J.H., Lu W., Ye C., Zheng Y., Cai Q., Gu K., Gao Y.T., Shu X.O., Zheng W. Cruciferous vegetables, the GSTP1 Ile105Val genetic polymorphism, and breast cancer risk. Am. J. Clin. Nutr. 2008, 87:753-760.
15. Moore L.E., Brennan P., Karami S., Hung R.J., Hsu C., Boffetta P., Toro J., Zaridze D., Janout V., Bencko V., Navratilova M., Szeszenia-Dabrowska N., Mates D., Mukeria A., Holcatova I., Welch R., Chanock S., Rothman N., Chow W.H. Glutathione S-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the Central and Eastern European Kidney Cancer Study. Carcinogenesis 2007, 28:1960-1964.
16. Spitz M.R., Duphorne C.M., Detry M.A., Pillow P.C., Amos C.I., Lei L., de Andrade M., Gu X., Hong W.K., Wu X. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol. Biomark. Prev. 2000, 9:1017-1020.
17. Zhao B., Seow A., Lee E.J., Poh W.T., Teh M., Eng P., Wang Y.T., Tan W.C., Yu M.C., Lee H.P. Dietary isothiocyanates, glutathione S-transferase -M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiol. Biomark. Prev. 2001, 10:1063-1067.
18. Seow A., Poh W.T., Teh M., Eng P., Wang Y.T., Tan W.C., Chia K.S., Yu M.C., Lee H.P. Diet, reproductive factors and lung cancer risk among Chinese women in Singapore: evidence for a protective effect of soy in nonsmokers. Int. J. Cancer 2002, 97:365-371.
19. Hara M., Hanaoka T., Kobayashi M., Otani T., Adachi H.Y., Montani A., Natsukawa S., Shaura K., Koizumi Y., Kasuga Y., Matsuzawa T., Ikekawa T., Sasaki S., Tsugane S. Cruciferous vegetables, mushrooms, and gastrointestinal cancer risks in a multicenter, hospital-based case-control study in Japan. Nutr. Cancer 2003, 46:138-147.
20. Giovannucci E., Rimm E.B., Liu Y., Stampfer M.J., Willett W.C. A prospective study of cruciferous vegetables and prostate cancer. Cancer Epidemiol. Biomark. Prev. 2003, 12:1403-1409.
21. Wang L.I., Giovannucci E.L., Hunter D., Neuberg D., Su L., Christiani D.C. Dietary intake of Cruciferous vegetables, Glutathione S-transferase (GST) polymorphisms and lung cancer risk in a Caucasian population. Cancer Causes Control 2004, 15:977-985.
22. Raghavan M., Knapp D.W., Bonney P.L., Dawson M.H., Glickman L.T. Evaluation of the effect of dietary vegetable consumption on reducing risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers. J. Am. Vet. Med. Assoc. 2005, 227:94-100.
23. Zhao H., Lin J., Grossman H.B., Hernandez L.M., Dinney C.P., Wu X. Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk. Int. J. Cancer 2007, 120:2208-2213.
24. Tang L., Zirpoli G.R., Guru K., Moysich K.B., Zhang Y., Ambrosone C.B., McCann S.E. Consumption of raw cruciferous vegetables is inversely associated with bladder cancer risk. Cancer Epidemiol. Biomark. Prev. 2008, 17:938-944.
25. Thomson C.A., Rock C.L., Caan B.J., Flatt S.W., Al-Delaimy W.A., Newman V.A., Hajek R.A., Chilton J.A., Pierce J.P. Increase in cruciferous vegetable intake in women previously treated for breast cancer participating in a dietary intervention trial. Nutr. Cancer 2007, 57:11-19.
26. Yuan J.M., Gago-Dominguez M., Castelao J.E., Hankin J.H., Ross R.K., Yu M.C. Cruciferous vegetables in relation to renal cell carcinoma. Int. J. Cancer 1998, 77:211-216.
27. Nechuta S., Caan B.J., Chen W.Y., Kwan M.L., Lu W., Cai H., Poole E.M., Flatt S.W., Zheng W., Pierce J.P., Shu X.O. Postdiagnosis cruciferous vegetable consumption and breast cancer outcomes: a report from the After Breast Cancer Pooling Project. Cancer Epidemiol. Biomark. Prev. 2013, 22:1451-1456.
28. Health and Behavior: The Interplay of Biological, Behavioral, and Societal Influences 2001, (Washington (DC)).
29. Shapiro T.A., Fahey J.W., Wade K.L., Stephenson K.K., Talalay P. Chemoprotective glucosinolates and isothiocyanates of broccoli sprouts: metabolism and excretion in humans. Cancer Epidemiol. Biomark. Prev. 2001, 10:501-508.
30. Shapiro T.A., Fahey J.W., Wade K.L., Stephenson K.K., Talalay P. Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables. Cancer Epidemiol. Biomark. Prev. 1998, 7:1091-1100.
31. Getahun S.M., Chung F.L. Conversion of glucosinolates to isothiocyanates in humans after ingestion of cooked watercress. Cancer Epidemiol. Biomark. Prev. 1999, 8:447-451.
32. Van Eylen D., Oey I., Hendrickx M., Van Loey A. Kinetics of the stability of broccoli (Brassica oleracea Cv. Italica) myrosinase and isothiocyanates in broccoli juice during pressure/temperature treatments. J. Agric. Food Chem. 2007, 55:2163-2170.
33. Chung F.L., Morse M.A., Eklind K.I., Lewis J. Quantitation of human uptake of the anticarcinogen phenethyl isothiocyanate after a watercress meal. Cancer Epidemiol. Biomark. Prev. 1992, 1:383-388.
34. Hecht S.S., Chung F.L., Richie J.P., Akerkar S.A., Borukhova A., Skowronski L., Carmella S.G. Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers. Cancer Epidemiol. Biomark. Prev. 1995, 4:877-884.
35. Ji Y., Kuo Y., Morris M.E. Pharmacokinetics of dietary phenethyl isothiocyanate in rats. Pharm. Res. 2005, 22:1658-1666.
36. Konsue N., Kirkpatrick J., Kuhnert N., King L.J., Ioannides C. Repeated oral administration modulates the pharmacokinetic behavior of the chemopreventive agent phenethyl isothiocyanate in rats. Mol. Nutr. Food Res. 2010, 54:426-432.
37. Ji Y., Morris M.E. Determination of phenethyl isothiocyanate in human plasma and urine by ammonia derivatization and liquid chromatography-tandem mass spectrometry. Anal. Biochem. 2003, 323:39-47.
38. Wu X., Zhou Q.H., Xu K. Are isothiocyanates potential anti-cancer drugs?. Acta Pharmacol. Sin. 2009, 30:501-512.
39. Morris M.E., Dave R.A. Pharmacokinetics and pharmacodynamics of phenethyl isothiocyanate: implications in breast cancer prevention. AAPS J. 2014, 16(4):705-713.
40. Seow A., Shi C.Y., Chung F.L., Jiao D., Hankin J.H., Lee H.P., Coetzee G.A., Yu M.C. Urinary total isothiocyanate (ITC) in a population-based sample of middle-aged and older Chinese in Singapore: relationship with dietary total ITC and glutathione S-transferase M1/T1/P1 genotypes. Cancer Epidemiol. Biomark. Prev. 1998, 7:775-781.
41. London S.J., Yuan J.M., Chung F.L., Gao Y.T., Coetzee G.A., Ross R.K., Yu M.C. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet 2000, 356:724-729.
42. Lin H.J., Probst-Hensch N.M., Louie A.D., Kau I.H., Witte J.S., Ingles S.A., Frankl H.D., Lee E.R., Haile R.W. Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol. Biomark. Prev. 1998, 7:647-652.
43. Seow A., Yuan J.M., Sun C.L., Van Den Berg D., Lee H.P., Yu M.C. Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study. Carcinogenesis 2002, 23:2055-2061.
44. Ambrosone C.B., McCann S.E., Freudenheim J.L., Marshall J.R., Zhang Y., Shields P.G. Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J. Nutr. 2004, 134:1134-1138.
45. Steck S.E., Gammon M.D., Hebert J.R., Wall D.E., Zeisel S.H. GSTM1, GSTT1, GSTP1, and GSTA1 polymorphisms and urinary isothiocyanate metabolites following broccoli consumption in humans. J. Nutr. 2007, 137:904-909.
46. Steck S.E., Gaudet M.M., Britton J.A., Teitelbaum S.L., Terry M.B., Neugut A.I., Santella R.M., Gammon M.D. Interactions among GSTM1, GSTT1 and GSTP1 polymorphisms, cruciferous vegetable intake and breast cancer risk. Carcinogenesis 2007, 28:1954-1959.
47. Lam T.K., Gallicchio L., Lindsley K., Shiels M., Hammond E., Tao X.G., Chen L., Robinson K.A., Caulfield L.E., Herman J.G., Guallar E., Alberg A.J. Cruciferous vegetable consumption and lung cancer risk: a systematic review. Cancer Epidemiol. Biomark. Prev. 2009, 18:184-195.
48. Epplein M., Wilkens L.R., Tiirikainen M., Dyba M., Chung F.L., Goodman M.T., Murphy S.P., Henderson B.E., Kolonel L.N., Le Marchand L. Urinary isothiocyanates; glutathione S-transferase M1, T1, and P1 polymorphisms; and risk of colorectal cancer: the Multiethnic Cohort Study. Cancer Epidemiol. Biomark. Prev. 2009, 18:314-320.
49. Riso P., Brusamolino A., Moro M., Porrini M. Absorption of bioactive compounds from steamed broccoli and their effect on plasma glutathione S-transferase activity. Int. J. Food Sci. Nutr. 2009, 60(Suppl. 1):56-71.
50. Yang G., Gao Y.T., Shu X.O., Cai Q., Li G.L., Li H.L., Ji B.T., Rothman N., Dyba M., Xiang Y.B., Chung F.L., Chow W.H., Zheng W. Isothiocyanate exposure, glutathione S-transferase polymorphisms, and colorectal cancer risk. Am. J. Clin. Nutr. 2010, 91:704-711.
51. Dyba M., Wang A., Noone A.M., Goerlitz D., Shields P., Zheng Y.L., Rivlin R., Chung F.L. Metabolism of isothiocyanates in individuals with positive and null GSTT1 and M1 genotypes after drinking watercress juice. Clin. Nutr. 2010, 29:813-818.
52. Vos R.M., Snoek M.C., van Berkel W.J., Muller F., van Bladeren P.J. Differential induction of rat hepatic glutathione S-transferase isoenzymes by hexachlorobenzene and benzyl isothiocyanate. Comparison with induction by phenobarbital and 3-methylcholanthrene. Biochem. Pharmacol. 1988, 37:1077-1082.
53. Hara A., Sakai N., Yamada H., Tanaka T., Kato K., Mori H., Sato K. Induction of glutathione S-transferase, placental type in T9 glioma cells by dibutyryladenosine 3',5'-cyclic monophosphate and modification of its expression by naturally occurring isothiocyanates. Acta Neuropathol. 1989, 79:144-148.
54. Sugie S., Okumura A., Tanaka T., Mori H. Inhibitory effects of benzyl isothiocyanate and benzyl thiocyanate on diethylnitrosamine-induced hepatocarcinogenesis in rats. Jpn. J. Cancer Res. 1993, 84:865-870.
55. Kolm R.H., Danielson U.H., Zhang Y., Talalay P., Mannervik B. Isothiocyanates as substrates for human glutathione transferases: structure-activity studies. Biochem. J. 1995, 311(Pt 2):453-459.
56. Meyer D.J., Crease D.J., Ketterer B. Forward and reverse catalysis and product sequestration by human glutathione S-transferases in the reaction of GSH with dietary aralkyl isothiocyanates. Biochem. J. 1995, 306(Pt 2):565-569.
57. van Lieshout E.M., Peters W.H., Jansen J.B. Effect of oltipraz, alpha-tocopherol, beta-carotene and phenethylisothiocyanate on rat oesophageal, gastric, colonic and hepatic glutathione, glutathione S-transferase and peroxidase. Carcinogenesis 1996, 17:1439-1445.
58. Ogawa K., Futakuchi M., Hirose M., Boonyaphiphat P., Mizoguchi Y., Miki T., Shirai T. Stage and organ dependent effects of 1-O-hexyl-2,3,5-trimethylhydroquinone, ascorbic acid derivatives, n-heptadecane-8-10-dione and phenylethyl isothiocyanate in a rat multiorgan carcinogenesis model. Int. J. Cancer 1998, 76:851-856.
59. Nakamura Y., Morimitsu Y., Uzu T., Ohigashi H., Murakami A., Naito Y., Nakagawa Y., Osawa T., Uchida K. A glutathione S-transferase inducer from papaya: rapid screening, identification and structure-activity relationship of isothiocyanates. Cancer Lett. 2000, 157:193-200.
60. McWalter G.K., Higgins L.G., McLellan L.I., Henderson C.J., Song L., Thornalley P.J., Itoh K., Yamamoto M., Hayes J.D. Transcription factor Nrf2 is essential for induction of NAD(P)H:quinone oxidoreductase 1, glutathione S-transferases, and glutamate cysteine ligase by broccoli seeds and isothiocyanates. J. Nutr. 2004, 134:3499S-3506S.
61. Hofmann T., Kuhnert A., Schubert A., Gill C., Rowland I.R., Pool-Zobel B.L., Glei M. Modulation of detoxification enzymes by watercress: in vitro and in vivo investigations in human peripheral blood cells. Eur. J. Nutr. 2009, 48:483-491.
62. Sharma R., Ellis B., Sharma A. Role of alpha class glutathione transferases (GSTs) in chemoprevention: GSTA1 and A4 overexpressing human leukemia (HL60) cells resist sulforaphane and curcumin induced toxicity. Phytother. Res. 2011, 25:563-568.
63. Krajka-Kuzniak V., Szaefer H., Bartoszek A., Baer-Dubowska W. Modulation of rat hepatic and kidney phase II enzymes by cabbage juices: comparison with the effects of indole-3-carbinol and phenethyl isothiocyanate. Br. J. Nutr. 2011, 105:816-826.
64. Tang L., Li G., Song L., Zhang Y. The principal urinary metabolites of dietary isothiocyanates, N-acetylcysteine conjugates, elicit the same anti-proliferative response as their parent compounds in human bladder cancer cells. Anti-Cancer Drugs 2006, 17:297-305.
65. Ji Y., Morris M.E. Effect of organic isothiocyanates on breast cancer resistance protein (ABCG2)-mediated transport. Pharm. Res. 2004, 21:2261-2269.
66. Ji Y., Morris M.E. Membrane transport of dietary phenethyl isothiocyanate by ABCG2 (breast cancer resistance protein). Mol. Pharm. 2005, 2:414-419.
67. Chiao J.W., Wu H., Ramaswamy G., Conaway C.C., Chung F.L., Wang L., Liu D. Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest. Carcinogenesis 2004, 25:1403-1408.
68. Nakajima M., Yoshida R., Shimada N., Yamazaki H., Yokoi T. Inhibition and inactivation of human cytochrome P450 isoforms by phenethyl isothiocyanate. Drug Metab. Dispos. 2001, 29:1110-1113.
69. Hecht S.S., Carmella S.G., Murphy S.E. Effects of watercress consumption on urinary metabolites of nicotine in smokers. Cancer Epidemiol. Biomark. Prev. 1999, 8:907-913.
70. Srivastava S.K., Xia H., Pal A., Hu X., Guo J., Singh S.V. Potentiation of benzo[a]pyrene-induced pulmonary and forestomach tumorigenesis in mice by d,l-buthionine-S, R-sulfoximine-mediated tissue glutathione depletion. Cancer Lett. 2000, 153:35-39.
71. Srivastava S.K., Watkins S.C., Schuetz E., Singh S.V. Role of glutathione conjugate efflux in cellular protection against benzo[a]pyrene-7,8-diol-9,10-epoxide-induced DNA damage. Mol. Carcinog. 2002, 33:156-162.
72. Navarro S.L., Chang J.L., Peterson S., Chen C., King I.B., Schwarz Y., Li S.S., Li L., Potter J.D., Lampe J.W. Modulation of human serum glutathione S-transferase A1/2 concentration by cruciferous vegetables in a controlled feeding study is influenced by GSTM1 and GSTT1 genotypes. Cancer Epidemiol. Biomark. Prev. 2009, 18:2974-2978.
73. Gum S.I., Cho M.K. Differential hepatic GSTA2 expression of arylalkyl isothiocyanates in vivo and in vitro: the molecular mechanism of gene induction by phenethyl isothiocyanate. Mol. Nutr. Food Res. 2013, 57:2223-2232.
74. Guo J., Pal A., Srivastava S.K., Orchard J.L., Singh S.V. Differential expression of glutathione S-transferase isoenzymes in murine small intestine and colon. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2002, 131:443-452.
75. Murillo G., Mehta R.G. Cruciferous vegetables and cancer prevention. Nutr. Cancer 2001, 41:17-28.
76. Hecht S.S. Inhibition of carcinogenesis by isothiocyanates. Drug Metab. Rev. 2000, 32:395-411.
77. Xiao D., Srivastava S.K., Lew K.L., Zeng Y., Hershberger P., Johnson C.S., Trump D.L., Singh S.V. Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis. Carcinogenesis 2003, 24:891-897.
78. Talalay P., Fahey J.W. Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J. Nutr. 2001, 131:3027S-3033S.
79. Boreddy S.R., Pramanik K.C., Srivastava S.K. Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway. Clin. Cancer Res. 2011, 17:1784-1795.
80. Sahu R.P., Srivastava S.K. The role of STAT-3 in the induction of apoptosis in pancreatic cancer cells by benzyl isothiocyanate. J. Natl. Cancer Inst. 2009, 101:176-193.
81. Kandala P.K., Srivastava S.K. Diindolylmethane-mediated Gli1 protein suppression induces anoikis in ovarian cancer cells in vitro and blocks tumor formation ability in vivo. J. Biol. Chem. 2012, 287:28745-28754.
82. Morse M.A., Amin S.G., Hecht S.S., Chung F.L. Effects of aromatic isothiocyanates on tumorigenicity, O6-methylguanine formation, and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Cancer Res. 1989, 49:2894-2897.
83. Wattenberg L.W. Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds. J. Natl. Cancer Inst. 1977, 58:395-398.
84. Adam-Rodwell G., Morse M.A., Stoner G.D. The effects of phenethyl isothiocyanate on benzo[a]pyrene-induced tumors and DNA adducts in A/J mouse lung. Cancer Lett. 1993, 71:35-42.
85. Aras U., Gandhi Y.A., Masso-Welch P.A., Morris M.E. Chemopreventive and anti-angiogenic effects of dietary phenethyl isothiocyanate in an N-methyl nitrosourea-induced breast cancer animal model. Biopharm. Drug Dispos. 2013, 34:98-106.
86. Singh S.V., Kim S.H., Sehrawat A., Arlotti J.A., Hahm E.R., Sakao K., Beumer J.H., Jankowitz R.C., Chandra-Kuntal K., Lee J., Powolny A.A., Dhir R. Biomarkers of phenethyl isothiocyanate-mediated mammary cancer chemoprevention in a clinically relevant mouse model. J. Natl. Cancer Inst. 2012, 104:1228-1239.
87. Fimognari C., Lenzi M., Hrelia P. Interaction of the isothiocyanate sulforaphane with drug disposition and metabolism: pharmacological and toxicological implications. Curr. Drug Metab. 2008, 9:668-678.
88. Gross-Steinmeyer K., Stapleton P.L., Liu F., Tracy J.H., Bammler T.K., Quigley S.D., Farin F.M., Buhler D.R., Safe S.H., Strom S.C., Eaton D.L. Phytochemical-induced changes in gene expression of carcinogen-metabolizing enzymes in cultured human primary hepatocytes. Xenobiotica 2004, 34:619-632.
89. Yoshigae Y., Sridar C., Kent U.M., Hollenberg P.F. The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation. Drug Metab. Dispos. 2013, 41:858-869.
90. Gross-Steinmeyer K., Stapleton P.L., Tracy J.H., Bammler T.K., Strom S.C., Eaton D.L. Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expression. Toxicol. Sci. 2010, 116:422-432.
91. Morris C.R., Chen S.C., Zhou L., Schopfer L.M., Ding X., Mirvish S.S. Inhibition by allyl sulfides and phenethyl isothiocyanate of methyl-n-pentylnitrosamine depentylation by rat esophageal microsomes, human and rat CYP2E1, and Rat CYP2A3. Nutr. Cancer 2004, 48:54-63.
92. Cheung K.L., Kong A.N. Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J. 2010, 12:87-97.
93. Saw C.L., Cintron M., Wu T.Y., Guo Y., Huang Y., Jeong W.S., Kong A.N. Pharmacodynamics of dietary phytochemical indoles I3C and DIM: induction of Nrf2-mediated phase II drug metabolizing and antioxidant genes and synergism with isothiocyanates. Biopharm. Drug Dispos. 2011, 32:289-300.
94. Konsue N., Ioannides C. Differential response of four human livers to modulation of phase II enzyme systems by the chemopreventive phytochemical phenethyl isothiocyanate. Mol. Nutr. Food Res. 2010, 54:1477-1485.
95. Konsue N., Ioannides C. Tissue differences in the modulation of rat cytochromes P450 and phase II conjugation systems by dietary doses of phenethyl isothiocyanate. Food Chem. Toxicol. 2008, 46:3677-3683.
96. Waris G., Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J. Carcinog. 2006, 5:14.
97. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
98. Yu R., Jiao J.J., Duh J.L., Tan T.H., Kong A.N. Phenethyl isothiocyanate, a natural chemopreventive agent, activates c-Jun N-terminal kinase 1. Cancer Res. 1996, 56:2954-2959.
99. Yu R., Mandlekar S., Harvey K.J., Ucker D.S., Kong A.N. Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity. Cancer Res. 1998, 58:402-408.
100. Huang C., Ma W.Y., Li J., Hecht S.S., Dong Z. Essential role of p53 in phenethyl isothiocyanate-induced apoptosis. Cancer Res. 1998, 58:4102-4106.
101. Guo Z., Smith T.J., Wang E., Eklind K.I., Chung F.L., Yang C.S. Structure-activity relationships of arylalkyl isothiocyanates for the inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism and the modulation of xenobiotic-metabolizing enzymes in rats and mice. Carcinogenesis 1993, 14:1167-1173.
102. Gupta P., Srivastava S.K. Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models. BMC Med. 2012, 10:80.
103. Tseng E., Scott-Ramsay E.A., Morris M.E. Dietary organic isothiocyanates are cytotoxic in human breast cancer MCF-7 and mammary epithelial MCF-12A cell lines. Exp. Biol. Med. 2004, 229:835-842.
104. Keum Y.S., Jeong W.S., Kong A.N. Chemoprevention by isothiocyanates and their underlying molecular signaling mechanisms. Mutat. Res. 2004, 555:191-202.
105. Chen Y.R., Wang W., Kong A.N., Tan T.H. Molecular mechanisms of c-Jun N-terminal kinase-mediated apoptosis induced by anticarcinogenic isothiocyanates. J. Biol. Chem. 1998, 273:1769-1775.
106. Yang Y.M., Conaway C.C., Chiao J.W., Wang C.X., Amin S., Whysner J., Dai W., Reinhardt J., Chung F.L. Inhibition of benzo(a)pyrene-induced lung tumorigenesis in A/J mice by dietary N-acetylcysteine conjugates of benzyl and phenethyl isothiocyanates during the postinitiation phase is associated with activation of mitogen-activated protein kinases and p53 activity and induction of apoptosis. Cancer Res. 2002, 62:2-7.
107. Trachootham D., Zhou Y., Zhang H., Demizu Y., Chen Z., Pelicano H., Chiao P.J., Achanta G., Arlinghaus R.B., Liu J., Huang P. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 2006, 10:241-252.
108. Zhang Y., Talalay P. Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic Phase 2 enzymes. Cancer Res. 1998, 58:4632-4639.
109. Lai K.C., Hsu S.C., Kuo C.L., Ip S.W., Yang J.S., Hsu Y.M., Huang H.Y., Wu S.H., Chung J.G. Phenethyl isothiocyanate inhibited tumor migration and invasion via suppressing multiple signal transduction pathways in human colon cancer HT29 cells. J. Agric. Food Chem. 2010, 58(20):11148-11155.
110. Wu X., Zhu Y., Yan H., Liu B., Li Y., Zhou Q., Xu K. Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells. BMC Cancer 2010, 10:269.
111. Hwang E.S., Lee H.J. Phenylethyl isothiocyanate and its N-acetylcysteine conjugate suppress the metastasis of SK-Hep1 human hepatoma cells. J. Nutr. Biochem. 2006, 17:837-846.
112. Wang X.H., Cavell B.E., Syed Alwi S.S., Packham G. Inhibition of hypoxia inducible factor by phenethyl isothiocyanate. Biochem. Pharmacol. 2009, 78:261-272.
113. Xiao D., Singh S.V. Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo. Cancer Res. 2007, 67:2239-2246.
114. Mi L., Hood B.L., Stewart N.A., Xiao Z., Govind S., Wang X., Conrads T.P., Veenstra T.D., Chung F.L. Identification of potential protein targets of isothiocyanates by proteomics. Chem. Res. Toxicol. 2011, 24:1735-1743.
115. Matzinger S.A., Crist K.A., Stoner G.D., Anderson M.W., Pereira M.A., Steele V.E., Kelloff G.J., Lubet R.A., You M. K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate. Carcinogenesis 1995, 16:2487-2492.
116. Gao N., Budhraja A., Cheng S., Liu E.H., Chen J., Yang Z., Chen D., Zhang Z., Shi X. Phenethyl isothiocyanate exhibits antileukemic activity in vitro and in vivo by inactivation of Akt and activation of JNK pathways. Cell Death Dis. 2011, 2:e140.
117. Loganathan S., Kandala P.K., Gupta P., Srivastava S.K. Inhibition of EGFR-AKT axis results in the suppression of ovarian tumors in vitro and in preclinical mouse model. PLoS One 2012, 7:e43577.
118. Okubo T., Washida K., Murakami A. Phenethyl isothiocyanate suppresses nitric oxide production via inhibition of phosphoinositide 3-kinase/Akt-induced IFN-gamma secretion in LPS-activated peritoneal macrophages. Mol. Nutr. Food Res. 2010, 54:1351-1360.
119. Gupta P., Adkins C., Lockman P., Srivastava S.K. Metastasis of breast tumor cells to brain is suppressed by phenethyl isothiocyanate in a novel in vivo metastasis model. PLoS One 2013, 8.
120. Beklemisheva A.A., Feng J., Yeh Y.A., Wang L.G., Chiao J.W. Modulating testosterone stimulated prostate growth by phenethyl isothiocyanate via Sp1 and androgen receptor down-regulation. Prostate 2007, 67:863-870.
121. Chen P.Y., Lin K.C., Lin J.P., Tang N.Y., Yang J.S., Lu K.W., Chung J.G. Phenethyl isothiocyanate (PEITC) inhibits the growth of human oral squamous carcinoma HSC-3 cells through G(0)/G(1) phase arrest and mitochondria-mediated apoptotic cell death. Evid. Based Complement. Alternat. Med. 2012, 2012:718320.
122. Jakubikova J., Cervi D., Ooi M., Kim K., Nahar S., Klippel S., Cholujova D., Leiba M., Daley J.F., Delmore J., Negri J., Blotta S., McMillin D.W., Hideshima T., Richardson P.G., Sedlak J., Anderson K.C., Mitsiades C.S. Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma. Haematologica 2011, 96:1170-1179.
123. Moon Y.J., Brazeau D.A., Morris M.E. Dietary phenethyl isothiocyanate alters gene expression in human breast cancer cells. Evid. Based Complement. Alternat. Med. 2011, (2011, pii: 462525).
124. Tang N.Y., Huang Y.T., Yu C.S., Ko Y.C., Wu S.H., Ji B.C., Yang J.S., Yang J.L., Hsia T.C., Chen Y.Y., Chung J.G. Phenethyl isothiocyanate (PEITC) promotes G2/M phase arrest via p53 expression and induces apoptosis through caspase- and mitochondria-dependent signaling pathways in human prostate cancer DU 145 cells. Anticancer Res. 2011, 31:1691-1702.
125. Wu C.L., Huang A.C., Yang J.S., Liao C.L., Lu H.F., Chou S.T., Ma C.Y., Hsia T.C., Ko Y.C., Chung J.G. Benzyl isothiocyanate (BITC) and phenethyl isothiocyanate (PEITC)-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of caspase-3, mitochondria dysfunction and nitric oxide (NO) in human osteogenic sarcoma U-2 OS cells. J. Orthop. Res. 2011, 29:1199-1209.
126. Pawlik A., Szczepanski M.A., Klimaszewska A., Gackowska L., Zuryn A., Grzanka A. Phenethyl isothiocyanate-induced cytoskeletal changes and cell death in lung cancer cells. Food Chem. Toxicol. 2012, 50:3577-3594.
127. Mi L., Gan N., Chung F.L. Isothiocyanates inhibit proteasome activity and proliferation of multiple myeloma cells. Carcinogenesis 2011, 32:216-223.
128. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266:2011-2015.
129. Mukherjee S., Bhattacharya R.K., Roy M. Targeting protein kinase C (PKC) and telomerase by phenethyl isothiocyanate (PEITC) sensitizes PC-3 cells towards chemotherapeutic drug-induced apoptosis. J. Environ. Pathol. Toxicol. Oncol. 2009, 28:269-282.
130. Mukherjee S., Dey S., Bhattacharya R.K., Roy M. Isothiocyanates sensitize the effect of chemotherapeutic drugs via modulation of protein kinase C and telomerase in cervical cancer cells. Mol. Cell. Biochem. 2009, 330:9-22.
131. Lee J.W., Cho M.K. Phenethyl isothiocyanate induced apoptosis via down regulation of Bcl-2/XIAP and triggering of the mitochondrial pathway in MCF-7 cells. Arch. Pharm. Res. 2008, 31:1604-1612.
132. Xiao D., Lew K.L., Zeng Y., Xiao H., Marynowski S.W., Dhir R., Singh S.V. Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential. Carcinogenesis 2006, 27:2223-2234.
133. Tusskorn O., Senggunprai L., Prawan A., Kukongviriyapan U., Kukongviriyapan V. Phenethyl isothiocyanate induces calcium mobilization and mitochondrial cell death pathway in cholangiocarcinoma KKU-M214 cells. BMC Cancer 2013, 13:571.
134. Stan S.D., Singh S.V., Whitcomb D.C., Brand R.E. Phenethyl isothiocyanate inhibits proliferation and induces apoptosis in pancreatic cancer cells in vitro and in a MIAPaca2 xenograft animal model. Nutr. Cancer 2014, 66:747-755.
135. Tusskorn O., Prawan A., Senggunprai L., Kukongviriyapan U., Kukongviriyapan V. Phenethyl isothiocyanate induces apoptosis of cholangiocarcinoma cells through interruption of glutathione and mitochondrial pathway. Naunyn Schmiedeberg's Arch. Pharmacol. 2013, 386:1009-1016.
136. Hahm E.R., Singh S.V. Bim contributes to phenethyl isothiocyanate-induced apoptosis in breast cancer cells. Mol. Carcinog. 2012, 51:465-474.
137. Wu X., Kassie F., Mersch-Sundermann V. Induction of apoptosis in tumor cells by naturally occurring sulfur-containing compounds. Mutat. Res. 2005, 589:81-102.
138. Wu X.J., Hua X. Targeting ROS: selective killing of cancer cells by a cruciferous vegetable derived pro-oxidant compound. Cancer Biol. Ther. 2007, 6:646-647.
139. Roy N., Elangovan I., Kopanja D., Bagchi S., Raychaudhuri P. Tumor regression by phenethyl isothiocyanate involves DDB2. Cancer Biol. Ther. 2013, 14:108-116.
140. Huong L.D., Shin J.A., Choi E.S., Cho N.P., Kim H.M., Leem D.H., Cho S.D. beta-Phenethyl isothiocyanate induces death receptor 5 to induce apoptosis in human oral cancer cells via p38. Oral Dis. 2012, 18:513-519.
141. Huong le D., Shim J.H., Choi K.H., Shin J.A., Choi E.S., Kim H.S., Lee S.J., Kim S.J., Cho N.P., Cho S.D. Effect of beta-phenylethyl isothiocyanate from cruciferous vegetables on growth inhibition and apoptosis of cervical cancer cells through the induction of death receptors 4 and 5. J. Agric. Food Chem. 2011, 59:8124-8131.
142. Pullar J.M., Thomson S.J., King M.J., Turnbull C.I., Midwinter R.G., Hampton M.B. The chemopreventive agent phenethyl isothiocyanate sensitizes cells to Fas-mediated apoptosis. Carcinogenesis 2004, 25:765-772.
143. Wang Y., Wei S., Wang J., Fang Q., Chai Q. Phenethyl isothiocyanate inhibits growth of human chronic myeloid leukemia K562 cells via reactive oxygen species generation and caspases. Mol. Med. Rep. 2014, 10:543-549.
144. Sakao K., Desineni S., Hahm E.R., Singh S.V. Phenethyl isothiocyanate suppresses inhibitor of apoptosis family protein expression in prostate cancer cells in culture and in vivo. Prostate 2012, 72:1104-1116.
145. Glick D., Barth S., Macleod K.F. Autophagy: cellular and molecular mechanisms. J. Pathol. 2010, 221:3-12.
146. Xue C., Pasolli H.A., Piscopo I., Gros D.J., Liu C., Chen Y., Chiao J.W. Mitochondrial structure alteration in human prostate cancer cells upon initial interaction with a chemopreventive agent phenethyl isothiocyanate. Cancer Cell Int. 2014, 14:30.
147. Bommareddy A., Hahm E.R., Xiao D., Powolny A.A., Fisher A.L., Jiang Y., Singh S.V. Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells. Cancer Res. 2009, 69:3704-3712.
148. Powolny A.A., Bommareddy A., Hahm E.R., Normolle D.P., Beumer J.H., Nelson J.B., Singh S.V. Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer. J. Natl. Cancer Inst. 2011, 103:571-584.
149. Mi L., Gan N., Chung F.L. Aggresome-like structure induced by isothiocyanates is novel proteasome-dependent degradation machinery. Biochem. Biophys. Res. Commun. 2009, 388:456-462.
150. Loureiro R.M., D'Amore P.A. Transcriptional regulation of vascular endothelial growth factor in cancer. Cytokine Growth Factor Rev. 2005, 16:77-89.
151. Kang L., Wang Z.Y. Breast cancer cell growth inhibition by phenethyl isothiocyanate is associated with down-regulation of oestrogen receptor-alpha36. J. Cell. Mol. Med. 2010, 14:1485-1493.
152. Syed Alwi S.S., Cavell B.E., Telang U., Morris M.E., Parry B.M., Packham G. In vivo modulation of 4E binding protein 1 (4E-BP1) phosphorylation by watercress: a pilot study. Br. J. Nutr. 2010, 104:1288-1296.
153. Izzotti A., Larghero P., Balansky R., Pfeffer U., Steele V.E., De Flora S. Interplay between histopathological alterations, cigarette smoke and chemopreventive agents in defining microRNA profiles in mouse lung. Mutat. Res. 2011, 717:17-24.
154. Gupta B., Chiang L., Chae K., Lee D.H. Phenethyl isothiocyanate inhibits hypoxia-induced accumulation of HIF-1alpha and VEGF expression in human glioma cells. Food Chem. 2013, 141:1841-1846.
155. Wu W.J., Zhang Y., Zeng Z.L., Li X.B., Hu K.S., Luo H.Y., Yang J., Huang P., Xu R.H. beta-phenylethyl isothiocyanate reverses platinum resistance by a GSH-dependent mechanism in cancer cells with epithelial-mesenchymal transition phenotype. Biochem. Pharmacol. 2013, 85:486-496.
156. Sakao K., Hahm E.R., Singh S.V. In vitro and in vivo effects of phenethyl isothiocyanate treatment on vimentin protein expression in cancer cells. Nutr. Cancer 2013, 65(Suppl. 1):61-67.
157. Chen H.J., Lin C.M., Lee C.Y., Shih N.C., Amagaya S., Lin Y.C., Yang J.S. Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling. Int. J. Oncol. 2013, 43:629-637.
158. Dey M., Kuhn P., Ribnicky D., Premkumar V., Reuhl K., Raskin I. Dietary phenethylisothiocyanate attenuates bowel inflammation in mice. BMC Chem. Biol. 2010, 10:4.
159. Tsai J.T., Liu H.C., Chen Y.H. Suppression of inflammatory mediators by cruciferous vegetable-derived indole-3-carbinol and phenylethyl isothiocyanate in lipopolysaccharide-activated macrophages. Mediat. Inflamm. 2010, 2010:293642.
160. Brown K.K., Blaikie F.H., Smith R.A., Tyndall J.D., Lue H., Bernhagen J., Winterbourn C.C., Hampton M.B. Direct modification of the proinflammatory cytokine macrophage migration inhibitory factor by dietary isothiocyanates. J. Biol. Chem. 2009, 284:32425-32433.
161. Li R.W., Li C., Wang T.T. Transcriptomic alterations in human prostate cancer cell LNCaP tumor xenograft modulated by dietary phenethyl isothiocyanate. Mol. Carcinog. 2013, 52:426-437.
162. Tsou M.F., Tien N., Lu C.C., Chiang J.H., Yang J.S., Lin J.P., Fan M.J., Lu J.J., Yeh S.P., Chung J.G. Phenethyl isothiocyanate promotes immune responses in normal BALB/c mice, inhibits murine leukemia WEHI-3 cells, and stimulates immunomodulations in vivo. Environ. Toxicol. 2011, 28(3):127-136.
163. Zhu J., Ghosh A., Coyle E.M., Lee J., Hahm E.R., Singh S.V., Sarkar S.N. Differential effects of phenethyl isothiocyanate and D, L-sulforaphane on TLR3 signaling. J. Immunol. 2013, 190:4400-4407.
164. Park H.J., Kim S.J., Park S.J., Eom S.H., Gu G.J., Kim S.H., Youn H.S. Phenethyl isothiocyanate regulates inflammation through suppression of the TRIF-dependent signaling pathway of Toll-like receptors. Life Sci. 2013, 92:793-798.
165. Xiao D., Singh S.V. Phenethyl isothiocyanate sensitizes androgen-independent human prostate cancer cells to docetaxel-induced apoptosis in vitro and in vivo. Pharm. Res. 2010, 27:722-731.
166. Barrera L.N., Cassidy A., Johnson I.T., Bao Y., Belshaw N.J. Epigenetic and antioxidant effects of dietary isothiocyanates and selenium: potential implications for cancer chemoprevention. Proc. Nutr. Soc. 2012, 71:237-245.
167. Manesh C., Kuttan G. Anti-tumour and anti-oxidant activity of naturally occurring isothiocyanates. J. Exp. Clin. Cancer Res. 2003, 22:193-199.
168. Prawan A., Keum Y.S., Khor T.O., Yu S., Nair S., Li W., Hu L., Kong A.N. Structural influence of isothiocyanates on the antioxidant response element (ARE)-mediated heme oxygenase-1 (HO-1) expression. Pharm. Res. 2008, 25:836-844.
169. Chen G., Chen Z., Hu Y., Huang P. Inhibition of mitochondrial respiration and rapid depletion of mitochondrial glutathione by beta-phenethyl isothiocyanate: mechanisms for anti-leukemia activity. Antioxid. Redox Signal. 2011, 15:2911-2921.
170. Xiao D., Singh S.V. p66Shc is indispensable for phenethyl isothiocyanate-induced apoptosis in human prostate cancer cells. Cancer Res. 2010, 70:3150-3158.
171. Syed Alwi S.S., Cavell B.E., Donlevy A., Packham G. Differential induction of apoptosis in human breast cancer cell lines by phenethyl isothiocyanate, a glutathione depleting agent. Cell Stress Chaperones 2012, 17:529-538.
172. Powolny A.A., Singh S.V. Differential response of normal (PrEC) and cancerous human prostate cells (PC-3) to phenethyl isothiocyanate-mediated changes in expression of antioxidant defense genes. Pharm. Res. 2010, 27:2766-2775.
173. Kojo S. Oxygen is the key factor associated with the difference between in vivo and in vitro effects of antioxidants. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E2028. (author reply E2029).
174. Pramanik K.C., Srivastava S.K. Apoptosis signal-regulating kinase 1-thioredoxin complex dissociation by capsaicin causes pancreatic tumor growth suppression by inducing apoptosis. Antioxid. Redox Signal. 2012, 17:1417-1432.
175. Lin R.K., Zhou N., Lyu Y.L., Tsai Y.C., Lu C.H., Kerrigan J., Chen Y.T., Guan Z., Hsieh T.S., Liu L.F. Dietary isothiocyanate-induced apoptosis via thiol modification of DNA topoisomerase IIalpha. J. Biol. Chem. 2011, 286:33591-33600.
176. Xiao Z., Mi L., Chung F.L., Veenstra T.D. Proteomic analysis of covalent modifications of tubulins by isothiocyanates. J. Nutr. 2012, 142:1377S-1381S.
177. Cheung K.L., Khor T.O., Yu S., Kong A.N. PEITC induces G1 cell cycle arrest on HT-29 cells through the activation of p38 MAPK signaling pathway. AAPS J. 2008, 10:277-281.
178. Hollenberg P.F., Kent U.M., Bumpus N.N. Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications. Chem. Res. Toxicol. 2008, 21:189-205.
179. Hudson T.S., Perkins S.N., Hursting S.D., Young H.A., Kim Y.S., Wang T.C., Wang T.T. Inhibition of androgen-responsive LNCaP prostate cancer cell tumor xenograft growth by dietary phenethyl isothiocyanate correlates with decreased angiogenesis and inhibition of cell attachment. Int. J. Oncol. 2012, 40:1113-1121.
180. Izzotti A., Larghero P., Cartiglia C., Longobardi M., Pfeffer U., Steele V.E., De Flora S. Modulation of microRNA expression by budesonide, phenethyl isothiocyanate and cigarette smoke in mouse liver and lung. Carcinogenesis 2010, 31:894-901.
181. Izzotti A., Calin G.A., Steele V.E., Cartiglia C., Longobardi M., Croce C.M., De Flora S. Chemoprevention of cigarette smoke-induced alterations of MicroRNA expression in rat lungs. Cancer Prev. Res. 2010, 3:62-72.
182. Conaway C.C., Jiao D., Kohri T., Liebes L., Chung F.L. Disposition and pharmacokinetics of phenethyl isothiocyanate and 6-phenylhexyl isothiocyanate in F344 rats. Drug Metab. Dispos. 1999, 27:13-20.
183. Yu C., Gong A.Y., Chen D., Solelo Leon D., Young C.Y., Chen X.M. Phenethyl isothiocyanate inhibits androgen receptor-regulated transcriptional activity in prostate cancer cells through suppressing PCAF. Mol. Nutr. Food Res. 2013, 57:1825-1833.
184. Jutooru I., Guthrie A.S., Chadalapaka G., Pathi S., Kim K., Burghardt R., Jin U.H., Safe S. Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents. Mol. Cell. Biol. 2014, 34:2382-2395.
185. Yu Z., Xu H. Effect of phenethyl isothiocyanate on expression of genes during differentiation process of mouse embryonic stem cells in vitro. Wei Sheng Yan Jiu 2008, 37:693-696.
186. Gerhauser C. Epigenetic impact of dietary isothiocyanates in cancer chemoprevention. Curr. Opin. Clin. Nutr. Metab. Care 2013, 16:405-410.
187. Wang L.G., Chiao J.W. Prostate cancer chemopreventive activity of phenethyl isothiocyanate through epigenetic regulation (review). Int. J. Oncol. 2010, 37:533-539.
188. Yan H., Zhu Y., Liu B., Wu H., Li Y., Wu X., Zhou Q., Xu K. Mitogen-activated protein kinase mediates the apoptosis of highly metastatic human non-small cell lung cancer cells induced by isothiocyanates. Br. J. Nutr. 2011, 106:1779-1791.
189. Liu Y., Chakravarty S., Dey M. Phenethylisothiocyanate alters site- and promoter-specific histone tail modifications in cancer cells. PLoS One 2013, 8:e64535.
190. Liu K., Cang S., Ma Y., Chiao J.W. Synergistic effect of paclitaxel and epigenetic agent phenethyl isothiocyanate on growth inhibition, cell cycle arrest and apoptosis in breast cancer cells. Cancer Cell Int. 2013, 13:10.
191. Cang S., Ma Y., Chiao J.W., Liu D. Phenethyl isothiocyanate and paclitaxel synergistically enhanced apoptosis and alpha-tubulin hyperacetylation in breast cancer cells. Exp. Hematol. Oncol. 2014, 3:5.
192. Sarkars R., Mukherjee S., Roy M. Targeting heat shock proteins by phenethyl isothiocyanate results in cell-cycle arrest and apoptosis of human breast cancer cells. Nutr. Cancer 2013, 65:480-493.
193. Huang S.H., Hsu M.H., Hsu S.C., Yang J.S., Huang W.W., Huang A.C., Hsiao Y.P., Yu C.C., Chung J.G. Phenethyl isothiocyanate triggers apoptosis in human malignant melanoma A375.S2 cells through reactive oxygen species and the mitochondria-dependent pathways. Hum. Exp. Toxicol. 2014, 33:270-283.
194. Cavell B.E., Syed Alwi S.S., Donlevy A.M., Proud C.G., Packham G. Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2. J. Nat. Prod. 2012, 75:1051-1057.
195. Wang X., Di Pasqua A.J., Govind S., McCracken E., Hong C., Mi L., Mao Y., Wu J.Y., Tomita Y., Woodrick J.C., Fine R.L., Chung F.L. Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships. J. Med. Chem. 2011, 54:809-816.
196. Gupta P., Kim B., Kim S.H., Srivastava S.K. Molecular targets of isothiocyanates in cancer: recent advances. Mol. Nutr. Food Res. 2014, 58(8):1685-1707.
197. Chan D.K., Miskimins W.K. Metformin and phenethyl isothiocyanate combined treatment in vitro is cytotoxic to ovarian cancer cultures. J. Ovarian Res. 2012, 5:19.
198. Tseng E., Kamath A., Morris M.E. Effect of organic isothiocyanates on the P-glycoprotein- and MRP1-mediated transport of daunomycin and vinblastine. Pharm. Res. 2002, 19:1509-1515.
199. Lee D.H., Kim D.W., Lee H.C., Lee J.H., Lee T.H. Phenethyl isothiocyanate sensitizes glioma cells to TRAIL-induced apoptosis. Biochem. Biophys. Res. Commun. 2014, 446:815-821.
200. Wang X., Govind S., Sajankila S.P., Mi L., Roy R., Chung F.L. Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin. Mol. Nutr. Food Res. 2011, 55:1572-1581.
201. Tang T., Song X., Liu Y.F., Wang W.Y. PEITC reverse multi-drug resistance of human gastric cancer SGC7901/DDP cell line. Cell Biol. Int. 2014, 38:502-510.
202. Hecht S.S., Kenney P.M., Wang M., Trushin N., Upadhyaya P. Effects of phenethyl isothiocyanate and benzyl isothiocyanate, individually and in combination, on lung tumorigenesis induced in A/J mice by benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Lett. 2000, 150:49-56.
203. Hecht S.S., Isaacs S., Trushin N. Lung tumor induction in A/J mice by the tobacco smoke carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene: a potentially useful model for evaluation of chemopreventive agents. Carcinogenesis 1994, 15:2721-2725.
204. Conaway C.C., Wang C.X., Pittman B., Yang Y.M., Schwartz J.E., Tian D., McIntee E.J., Hecht S.S., Chung F.L. Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. Cancer Res. 2005, 65:8548-8557.
205. Staretz M.E., Koenig L.A., Hecht S.S. Effects of long term dietary phenethyl isothiocyanate on the microsomal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats. Carcinogenesis 1997, 18:1715-1722.
206. Sticha K.R., Kenney P.M., Boysen G., Liang H., Su X., Wang M., Upadhyaya P., Hecht S.S. Effects of benzyl isothiocyanate and phenethyl isothiocyanate on DNA adduct formation by a mixture of benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Carcinogenesis 2002, 23:1433-1439.
207. Izzotti A., Balansky R.M., Dagostini F., Bennicelli C., Myers S.R., Grubbs C.J., Lubet R.A., Kelloff G.J., De Flora S. Modulation of biomarkers by chemopreventive agents in smoke-exposed rats. Cancer Res. 2001, 61:2472-2479.
208. Boysen G., Kenney P.M., Upadhyaya P., Wang M., Hecht S.S. Effects of benzyl isothiocyanate and 2-phenethyl isothiocyanate on benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism in F-344 rats. Carcinogenesis 2003, 24:517-525.
209. Staretz M.E., Foiles P.G., Miglietta L.M., Hecht S.S. Evidence for an important role of DNA pyridyloxobutylation in rat lung carcinogenesis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: effects of dose and phenethyl isothiocyanate. Cancer Res. 1997, 57:259-266.
210. Kassie F., Melkamu T., Endalew A., Upadhyaya P., Luo X., Hecht S.S. Inhibition of lung carcinogenesis and critical cancer-related signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-l-cysteine, indole-3-carbinol and myo-inositol, alone and in combination. Carcinogenesis 2010, 31:1634-1641.
211. Kassie F., Matise I., Negia M., Lahti D., Pan Y., Scherber R., Upadhyaya P., Hecht S.S. Combinations of N-Acetyl-S-(N-2-Phenethylthiocarbamoyl)-l-Cysteine and myo-inositol inhibit tobacco carcinogen-induced lung adenocarcinoma in mice. Cancer Prev. Res. 2008, 1:285-297.
212. Ye B., Zhang Y.X., Yang F., Chen H.L., Xia D., Liu M.Q., Lai B.T. Induction of lung lesions in Wistar rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its inhibition by aspirin and phenethyl isothiocyanate. BMC Cancer 2007, 7:90.
213. Balansky R., Ganchev G., Iltcheva M., Steele V.E., De Flora S. Prevention of cigarette smoke-induced lung tumors in mice by budesonide, phenethyl isothiocyanate, and N-acetylcysteine. Int. J. Cancer 2010, 126:1047-1054.
214. D'Agostini F., Mastracci L., Izzotti A., Balansky R., Pennisi T.M., Steele V.E., De Flora S. Modulation by phenethyl isothiocyanate and budesonide of molecular and histopathologic alterations induced by environmental cigarette smoke in mice. Cancer Prev. Res. 2009, 2:546-556.
215. Micale R.T., D'Agostini F., Steele V.E., La Maestra S., De Flora S. Budesonide and phenethyl isothiocyanate attenuate DNA damage in bronchoalveolar lavage cells of mice exposed to environmental cigarette smoke. Curr. Cancer Drug Targets 2008, 8:703-708.
216. Mi L., Xiao Z., Hood B.L., Dakshanamurthy S., Wang X., Govind S., Conrads T.P., Veenstra T.D., Chung F.L. Covalent binding to tubulin by isothiocyanates. A mechanism of cell growth arrest and apoptosis. J. Biol. Chem. 2008, 283:22136-22146.